Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile;Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile

Revista Medica de Chile

Volumn 139, Issue 4, 2011, Pages 467-473

  Araya, Pamela ^a   Velasco, Maritza ^a   Tognarelli, Javier ^a   Arias, Fabiola ^a   Leiva, Tamara ^a   Sccapatticio, Angélica ^a   Alviz, Pablo ^a   Fernández, Jorge ^a  

^a INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

Author keywords

Drug resistance, microbial; Mutation; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL DNA; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TUBERCULOSTATIC AGENT; VGLL1 PROTEIN, HUMAN;

ARTICLE; BACTERIAL GENE; CHILE; DRUG EFFECT; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION;

ANTITUBERCULAR AGENTS; CHILE; DNA, BACTERIAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79961037666     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872011000400008     Document Type: Article

References (34)

1. Global tuberculosis control: WHO report 2010. Geneva, World Health Organization (WHO/HTM/TB/2010.7).
2. Leung ET, Ho PL, Yuen KY, Woo WL, Lam TH, Kao RY, et al. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 2006; 50: 1075-8.
3. Dahle U, Sanven P, Heldal E, Mannsaaker T, Caugant D. Deciphering an outbreak of Drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 67-72.
4. Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Multidrug-resistant and extensively drugresistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev Anti Infect Ther 2007; 5: 857-71.
5. Minsal. cl. Programa Nacional del Control de la Tuberculosis. Manual de organización y normas técnicas 2005. Available from: http://www.redsalud.gov.cl/archivos/ tuberculosis.
6. Riquelme MC, Velasco M, Rodríguez L. Actualización de la resistencia a drogas antituberculosas en Chile, 2006. Rev Enf Respir 2008; 24; 60-5.
7. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
8. Bartfai Z, Somoskövi A, Ködmön C, Szabo N, Puskas E, Kosztolanyi L, et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol. 2001; 39: 3736-9.
9. Nikolayevsky V, Brown T, Balabanova Y, Ruddy M, Fedorin I, Drobniewski F. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol 2004; 42(10): 4498-502.
10. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 2002; 46: 1417-24.
11. Musser JM, Kapur V, Williams DL, Kreiswirth BN, Van Soolingen D, Van Embden JD. Characterization of the catalase-peroxidase gene katG and inhA locus in isoniazid-resistant and-susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 1996; 173: 196-202.
12. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Takiff HE, et al. Genotyping assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997; 35: 719-23.
13. Kelley CL, Rouse DA, Morris SL. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1997; 41: 2057-8.
14. Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006; 50: 2640-9.
15. Marttila HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, et al. A Ser315Thr substitution in Kat G is predominant in genetically heterogeneous multidrugresistant Mycobacterium tuberculosis isolates originating from the St Petersburg area in Russia. Antimicrob Agents Chemother 1998; 42: 2443-5.
16. Van Soolingen D, De Haas PE, Van Doorn HR, Kuijper E, Rinder H, et al. Mutations at amino acid position 315 of the kat G gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 2000; 182: 1788-90.
17. Tracevska T, Jansone I, Broka L, Marga O, Baumanis V. Mutations in the rpoβ and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002; 40: 3789-92.
18. Ramaswamy S, Dou S, Rendon A, Yang Z, Cave D, Graviss E. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiolo 2004; 53; 107-13.
19. Alcaide F, Pfyffer G, Telenti A. Role of embB innatural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 1997; 41: 2270-3.
20. Ramaswamy S, Amin A, Göksel S, Stager C, Dou S, Sahly H, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2000; 44: 326-36.
21. Shen X, Shen GM, Wu J, Gui XH, Li X, Mei J, et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 2618-20.
22. Giannoni F, Iona E, Sementilli F, Brunori L, Pardini M, Battista G, et al. Evaluation of a new lineprobe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob. agents Chemother 2005; 49: 2928-33.
23. Ministerio de Salud de Brasil. Manual Nacional de Vigilancia de laboratorios de tuberculosis y otras micobacterias. 2008. p. 393-403.
24. Van Embden JDA, Crawford JT, Dale JW, Gicquel B, Hermans P, McAdam R, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31; 406-9.
25. Siddiqi N, Shamim M, Hussain S, Choudhary K, Ahmed N, Prachee G, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-50.
26. Persing DH. PCR protocols for emerging infectious disease. American Society for Microbiology, Washington, 1996. p. 114-49.
27. Lee H, Myoung H, Bang H, Bai G, Kim S, Kim J, et al. Mutations in the embB locus among Korean clinical isolates of mycobacterium tuberculosis resistant to etambutol. Yonsei Med J 2002; 43: 59-64.
28. Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, Farrar J. Mutations prevalent among rifampin-and isoniazidresistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 2006; 44: 2333-7.
29. Hillemann D, Weizenegger M, Kubica T, Ritchter E, Niemann S. Use of the genotypeMTBDR assay for rapid detection of rifampin and isoniazida resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2000; 543: 3699-703.
30. Heep M, Brandstätter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S, et al. Frequency of rpoβ mutations inside and outside the cluster I region in rifampinresistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol. 2001; 39: 107-10.
31. Zaker Bostanabad S, Titov LP, Slizen VV, Taghikhani M, Bahrmand A. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients. Tuberk Toraks 2007; 55: 231-7.
32. Rouse D, De Vito J, Li Z, Byer H, Morris S. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalasa-oeroxidase activities and isoniazid resistance. Mol Microbio 1996; 22: 583-92.
33. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, Zwolska Z, Kirikae F, Toyota E, et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 179-92.
34. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis and resistance. Lancet Infect Dis 2003; 3: 432-42.